Safety, Tolerability, and Pharmacodynamics of RDX5791 in Healthy Volunteers

NCT02796131 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

105

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: RDX5791
DRUG: Placebo

Sponsor

Ardelyx